amonafide has been researched along with amsacrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flanagan, JU; Kemp, CA; Maréchal, JD; Paine, MJ; Roberts, GC; Sutcliffe, MJ; van Eldik, AJ; Wolf, CR | 1 |
| Andersson, BS; Bakic, M; Beran, M; Newman, RA; Silberman, LE; Zwelling, LA | 1 |
2 other study(ies) available for amonafide and amsacrine
| Article | Year |
|---|---|
Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
Topics: Binding Sites; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Factual; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2004 |
In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
Topics: Adenine; Amsacrine; Cell Line; Clone Cells; DNA; DNA Topoisomerases, Type I; Doxorubicin; Electrophoresis, Agar Gel; Humans; Imides; In Vitro Techniques; Intercalating Agents; Isoquinolines; Leukemia, Myeloid, Acute; Mathematics; Naphthalimides; Organophosphonates | 1987 |